Because IFN inhibits the Th2 immune pattern [11], the data suggest that the cytokine shows a long-lasting immunomodulatory action in EGPA, which persist even after treatment has been terminated. This evidence concerns the gene IFNA1 and eosinophilic granulomatosis with polyangiitis.